Bidil Tablet, Film Coated
Product Images NDC 24338-010
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Bidil (NDC 24338-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Bidil 02)
Figure 1 (Bidil 03)
Figure 2 (Bidil 04)
This is a Kaplan-Meier plot of time to the first hospitalization for heart failure in black patients using BiDil compared to placebo, showing a 39% risk reduction in the first hospitalization for heart failure. The x-axis represents the time in days, while the y-axis shows the percent of patients without hospitalization. The plot demonstrates that BiDil reduces the risk of heart failure hospitalization significantly compared to the placebo group.*
Figure 3 (Bidil 05)
Figure 4 (Bidil 06)
Principal Display Panel (180 Tablet Bottle Label)
This is a description of a medication called BiDil. The medication comes as 90 tablets in a bottle with an NDC code of 24338-010-09. The tablets contain a combination of isosorbide dinitrate and hydralazine hydrochloride (20mg and 3765mg, respectively). The medication should be stored at room temperature between 15°C - 30°C (59°F - 86°F). The rest of the text seems to be unreadable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.